There is 1 paper on urinary C3M in aging research: 1 trial in people.
1 paper studies it3 findings
See all 1 papers on urinary C3M
“Urinary C3M was positively associated with future eGFR, with a steeper slope in the combination therapy group than in the RASi monotherapy group (P < 0.001).”
- Human trial1
Interventions
2Renin-angiotensin system inhibitors
downin humans1
1 study
Renin-angiotensin system inhibitors
downin humans1
Renin-angiotensin system inhibitors are linked with lower urinary C3M in humans (RASi monotherapy group; levels stable with combination therapy).
“urinary C3M levels remained stable, whereas levels decreased with RASi monotherapy, suggesting altered kidney ECM turnover.”
HumansRASi monotherapy group; levels stable with combination therapykidneyn = 229
American journal of physiology. Cell physiology
Renin-angiotensin system inhibitors + GLP-1 receptor agonists
upin humans1
1 study
Renin-angiotensin system inhibitors + GLP-1 receptor agonists
upin humans1
Renin-angiotensin system inhibitors + GLP-1 receptor agonists are linked with higher urinary C3M in humans (compared with RASi monotherapy).
“Combination therapy (RASi + GLP-1 RA) was associated with higher urinary C3M levels compared with RASi monotherapy (P = 0.036).”
Humanscompared with RASi monotherapykidneyn = 229
American journal of physiology. Cell physiology
More on Renin-angiotensin system inhibitors + GLP-1 receptor agonists
Associations
1Estimated glomerular filtration rate
upin humans1
1 study
Estimated glomerular filtration rate
upin humans1
Urinary C3M predicts estimated glomerular filtration rate in humans (steeper slope in the combination therapy group).
“Urinary C3M was positively associated with future eGFR, with a steeper slope in the combination therapy group than in the RASi monotherapy group (P < 0.001).”
Humanssteeper slope in the combination therapy groupkidneyn = 229
American journal of physiology. Cell physiology